Android app on Google Play

PDL BioPharma, Inc. (PDLI) Tops Q4 EPS 2c

March 1, 2013 4:06 PM EST Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q4 EPS of $34.00, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $86 million versus the consensus estimate of $86.08 million.

For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment